Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04130776 · ClinicalTrials.gov registry record
4Kscore Using Serum Stored Uncentrifuged
A clinical trial, sponsored by OPKO Health.
- Completed
- Registry status
- 64
- Enrollment target
NCT04130776: Completed study, sponsored by OPKO Health.
NCT04130776 is a clinical trial that has completed, run by OPKO Health. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04130776 has completed, sponsored by OPKO Health.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate whether storage of serum uncentrifuged is an allowable preanalytical procedure
Primary Outcome
Measure tPSA in serum samples at day 0, 1, 2 and 3
Interventions
- DIAGNOSTIC_TEST Measurement of four prostate-specific kallikreins for the 4Kscore Test when serum stored uncentrifuged
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-10-04 |
| Est. Completion | 2018-10-31 |
What the finished NCT04130776 record still lists
NCT04130776 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Measurement of four prostate-specific kallikreins for the 4Kscore Test when serum stored uncentrifuged is the first listed.
NCT04130776 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04130776 about?
NCT04130776 is a clinical study titled "4Kscore Using Serum Stored Uncentrifuged". The purpose of the study is to evaluate whether storage of serum uncentrifuged is an allowable preanalytical procedure
What is the current status of trial NCT04130776?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2017-10-04. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT04130776?
The interventions under investigation include: Measurement of four prostate-specific kallikreins for the 4Kscore Test when serum stored uncentrifuged (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04130776?
This trial is sponsored by OPKO Health, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI